Yulian Zhang 张玉莲

Yulian Zhang 张玉莲 has extensive work experience in the pharmaceutical and biotechnology industry. Their current position is Vice President of Global Business Development at Triastek, Inc. (from December 2022). Prior to this, Yulian held the role of Executive Director at FUSION Bioventures (from February 2021 to December 2022) and Executive Director at Klus Pharma, a subsidiary of Kelun Pharma (from July 2019 to 2021). Yulian also served as Director Of Business Development at Sichuan Kelun Pharmaceutical Co., Ltd. (from 2017 to 2019) and Associate Director at Actinium Pharmaceuticals, Inc. (from 2015 to 2017). Earlier in their career, Yulian held positions such as Senior Scientist at Blueprint Medicines Corporation (from 2012 to 2014), Senior Scientist, Medicinal Chemistry at Lexicon Pharmaceutical (from 2004 to 2012), Scientist, Medicinal Chemist at Vertex Pharmaceutical (from 2002 to 2004), and Research Associate at GSK (from 1999 to 2002).

Yulian Zhang 张玉莲's education history begins with their Bachelor's degree in Chemistry from Jilin University, which they obtained from 1990 to 1994. After that, they pursued a Ph.D in Organic Chemistry from Temple University, completing it between 1996 and 2002. Later, Yulian attended New York University and earned their Master of Business Administration (MBA) degree with a specialization in Finance from 2006 to 2010.